Johnson Thomas is an Endocrinology/Metabolic physician. OpenAlex indexes 70 publications with 756 citations (h-index 16); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Carman Ave
Apt # 2f
East Meadow, NY 115541147
Telephone
417-888-6793Registry record last updated 19 Feb 2015.
Clinical trials
- ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO)
Sponsor: IHF GmbH - Institut für Herzinfarktforschung
- Effect of Ultrasound Guided Laser Ablation Therapy on Symptomatic Benign Thyroid Nodules
Sponsor: Johnson Thomas
- Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration
Sponsor: The National Retina Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20254 payments
- Sequel Med Tech, LLCProgram year20253 payments
- KYOWA KIRIN, INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
59.2%Insulin Analog19.7%Lantus Solostar32%Basaglar Kwikpen U-10010%Tresiba Flextouch U-1009%Toujeo Solostar9%Insulin Lispro Kwikpen U-1008%Novolog Flexpen7%Humalog Kwikpen U-1006%Tresiba Flextouch U-2005%Novolog4%Humalog3%Fiasp Flextouch3%Soliqua 100-332%Toujeo Max Solostar2%Insulin Lispro2%Part D<11 patientsGLP-1 receptor agonist15.3%Ozempic60%Mounjaro25%Trulicity13%Rybelsus2%Part D<11 patients+ 7 more classes in this area
Hormonal (systemic)
26.1%l-Thyroxine20.3%Levothyroxine Sodium93%Synthroid8%Part D≥216 patientsThyroid Hormone Synthesis Inhibitor3.8%Methimazole100%Part D≥43 patients+ 4 more classes in this area
Cardiovascular
6.9%Statin5%Atorvastatin Calcium60%Rosuvastatin Calcium32%Simvastatin8%Part D<11 patientsACE inhibitor1%Lisinopril100%Part D≥11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Artificial Intelligence Applications in Thyroid Cancer Care
The Journal of Clinical Endocrinology & Metabolism
2025 - Improving Diagnostic Precision in Thyroid Pathology by Synergistic Use of AI and Molecular Markers
Graduate Medical Education Research Journal
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”